Umbilical Cord Blood Betaine in Infants Born Small for Gestational Age

Insights

Elevated betaine levels in cord blood are linked to higher risks of small-for-gestational-age infants. This suggests betaine dysregulation may impair fetal growth and impact birth outcomes.

Area of Science:

  • Perinatal medicine
  • Maternal-fetal medicine
  • Nutritional biochemistry

Background:

  • Birth weight is crucial for fetal health and predicts child development.
  • Poor fetal growth, indicated by small-for-gestational-age (SGA) status, has long-term health implications.
  • Understanding factors influencing fetal growth is essential for improving neonatal outcomes.

Purpose of the Study:

  • To investigate the association between betaine concentration in cord plasma and the incidence of small-for-gestational-age (SGA) infants.
  • To determine if betaine levels correlate with other lipid parameters in newborns.
  • To explore the relationship between betaine levels and anthropometric measurements like birth weight and length.

Main Methods:

  • A case-control study involving 141 mother-infant pairs was conducted at Chongqing Maternal and Child Health Hospital.
  • Participants were categorized into small-for-gestational-age (SGA) and appropriate-for-gestational-age (AGA) groups based on gestational age and birth weight.
  • Cord plasma betaine concentrations were quantified using high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS).

Main Results:

  • Cord plasma betaine concentrations were significantly higher in the small-for-gestational-age (SGA) group compared to the appropriate-for-gestational-age (AGA) group.
  • Betaine levels did not show a correlation with plasma lipid profiles (triglycerides, LDL, HDL, total cholesterol).
  • Adjusted analyses revealed a negative correlation between birth weight and birth length with betaine levels, indicating higher betaine is associated with poorer growth.

Conclusions:

  • Elevated cord blood betaine concentration is independently associated with an increased risk of small-for-gestational-age (SGA) infants.
  • Betaine dysregulation may represent a novel risk factor for impaired fetal growth.
  • Further research is warranted to elucidate the mechanisms underlying betaine's role in fetal development.
Abstract